Similar Papers

Paper Title
Journal
Date
Author
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study.
Noa Biran ...
The Lancet Rheumatology | VOL. 2
Noa Biran, et. al.Noa Biran ...
14 Aug 2020
Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study.
Yutaro Yamada ... Kentaro Inui
Clinical Rheumatology | VOL. 39
Yutaro Yamada, et. al.Yutaro Yamada ... Kentaro Inui
14 Jan 2020
The conundrum of interleukin-6 blockade in COVID-19.
Corrado Campochiaro ... Lorenzo Dagna
The Lancet. Rheumatology | VOL. 2
Corrado Campochiaro, et. al.Corrado Campochiaro ... Lorenzo Dagna
14 Aug 2020
Clinical trial participation among patients enrolled in the Glioma Outcomes Project.
Susan M Chang ... Fred G Barker
Cancer | VOL. 94
Susan M Chang, et. al.Susan M Chang ... Fred G Barker
14 May 2002
View more papers

More From: Chest

Paper Title
Journal
Date
Author
Trajectories of interferon-gamma release assay results over two years in independent cohorts from China, South Africa, Tanzania, and the United States
Cheng Chen ... Leonardo Martinez
CHEST | VOL. -
Cheng Chen, et. al.Cheng Chen ... Leonardo Martinez
01 Feb 2025
Dupilumab Improves Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS.
Surya P Bhatt ... Lacey B Robinson
Chest | VOL. -
Surya P Bhatt, et. al.Surya P Bhatt ... Lacey B Robinson
31 Jan 2025
How I Do It: Communicating to Patients and Families about Post Intensive Care Syndrome.
Mark L Rolfsen ... E Wesley Ely
Chest | VOL. -
Mark L Rolfsen, et. al.Mark L Rolfsen ... E Wesley Ely
30 Jan 2025
Hermansky-Pudlak Syndrome in the United States.
Andrew Engel ... Jesse Roman
Chest | VOL. -
Andrew Engel, et. al.Andrew Engel ... Jesse Roman
30 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.